Clinical trial NCT05326321: Effect of Virtual Reality Glasses in The Arteriovenous Fistule Cannulation Processon Paın and Patient Satisfaction
Official title: Effect of Virtual Reality Headset Glasses Used in The Arteriovenous Fistule Cannulation Processon Paın and Patient Satisfaction
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Arteriovenous Fistula
Keywords: Virtual Reality Glasses
Nursing
Pain
Patient Satisfaction
Lead sponsor: Mersin University
Sponsor class: OTHER
First posted: 2022-04-13
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Maximum age (years): 90
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Prospective, parallel, two-arm, randomized controlled clinical trial
Primary purpose: SUPPORTIVE_CARE

Brief summary: This research was conducted as a randomized controlled experimental study aiming to determine the impact of virtual reality glasses used in the AVF process on the pain felt by patients and patient satisfaction.

Detailed description: Chronic kidney disease (CKD) is a progressive, irreversible renal disease in which the ability of the body to maintain the balance of metabolism, fluid and electrolytes fails. Chronic kidney disease (CKD) is one of the major health problems with an increasing prevalence in the World. Hemodialysis as one of the most common methods of renal replacement therapy is a stressful procedure despite to maintain the survival of patients with chronic kidney disease that permanent and safe vascular access is one of the requirements of a successful hemodialysis. The pain of AVF puncture is common among the patients undergoing HD as acute and chronic pain which reported in more than 82% and 92% of them, respectively. Experience of the arteriovenous fistula puncture-related pain can have unpleasant effects on the patients, it causes that hemodialysis patients experience more disability, depression, irritability, and insomnia than other patients in adapting to stress. Experiencing continued pain can also affect the level of hemodialysis acceptance in patients and ultimately decrease quality of life. Therefore, pain control is an important priority in these patients.

Eligibility criteria: Inclusion Criteria:

* Receiving HD treatment
* Open to communication
* Fully oriented
* Without vision, hearing and perception problems
* Without any psychiatric illness
* Without a history of seizures such as epilepsy
* HD treatment administered via AVF
* İn the last day, no injection was made into any artery or vein from the place where the intervention will be performed
* Without any signs of infection such as redness, swelling, open wound in the area where the intervention will be performed
* Standardized Mini Mental Test value is 24 points and above
* One-time needle attempt from AV

Exclusion Criteria:

* Refusing to participate in the study
* under the age of 18
* Can't speak Turkish
* Closed to communication and not fully oriented
* Visual, hearing and perception problems
* Any psychiatric illness
* Having a history of seizures such as epilepsy
* HD treatment not administered via AVF
* Injection into any artery or vein from the place where the intervention will be performed in the last day,
* Any signs of infection such as redness, swelling, open wound in the area to be operated
* Using any pain medication before the procedure on the same day
* SMMT value below 24 in patients over 65 years of age
* Cannulation procedure not performed with a 16 G AVF needle
* Patients with multiple injections from the AVF

Primary outcomes:
measure: Pain evaluated using the Visual Analog Scale
timeFrame: Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses)
Secondary outcomes:
measure: Blood pressure
timeFrame: Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses)
measure: Heart rate
timeFrame: Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses)
measure: respiratory rate
timeFrame: Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses)
measure: peripheral oxygen saturation
timeFrame: Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses)
Other outcomes:
Locations:
city: Mersin
country: Turkey
facility: Mersin University
Study officials:
affiliation: Pozantı State Hospital
name: Hatice Şen, Master
role: PRINCIPAL_INVESTIGATOR
References: